Nifty
Sensex
:
:
22795.90
75311.06
-117.25 (-0.51%)
-424.90 (-0.56%)

Chemicals

Rating :
N/A

BSE: 516072 | NSE: VISHNU

452.70
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  440.00
  •  474.75
  •  440.00
  •  437.65
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  629356
  •  2905.49
  •  559.65
  •  247.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,988.80
  • 25.89
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,231.16
  • 0.07%
  • 3.43

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 68.36%
  • 2.33%
  • 17.93%
  • FII
  • DII
  • Others
  • 0.7%
  • 6.91%
  • 3.77%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.24
  • 12.48
  • 4.29

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.08
  • 19.69
  • 5.13

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.54
  • 35.38
  • 7.50

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.72
  • 17.48
  • 19.06

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.08
  • 3.70
  • 4.61

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.14
  • 10.71
  • 11.86

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
371.22
303.58
22.28%
343.84
307.94
11.66%
338.87
300.73
12.68%
300.36
335.93
-10.59%
Expenses
307.72
262.63
17.17%
298.65
261.96
14.01%
283.25
249.63
13.47%
236.83
274.70
-13.79%
EBITDA
63.50
40.95
55.07%
45.19
45.98
-1.72%
55.62
51.10
8.85%
63.53
61.22
3.77%
EBIDTM
17.11%
13.49%
13.14%
14.93%
16.41%
16.99%
21.15%
18.23%
Other Income
2.99
4.10
-27.07%
3.90
2.94
32.65%
2.73
2.23
22.42%
3.18
2.72
16.91%
Interest
10.26
9.13
12.38%
9.57
9.20
4.02%
9.12
9.15
-0.33%
9.24
8.83
4.64%
Depreciation
11.81
8.85
33.45%
9.08
8.89
2.14%
9.14
7.11
28.55%
8.70
6.51
33.64%
PBT
44.42
27.07
64.09%
30.45
30.83
-1.23%
40.09
37.07
8.15%
48.77
48.61
0.33%
Tax
10.03
6.32
58.70%
7.60
6.84
11.11%
9.62
8.45
13.85%
21.04
12.97
62.22%
PAT
34.40
20.76
65.70%
22.84
23.99
-4.79%
30.46
28.62
6.43%
27.73
35.64
-22.19%
PATM
9.27%
6.84%
6.64%
7.79%
8.99%
9.52%
9.23%
10.61%
EPS
5.25
3.17
65.62%
3.49
3.66
-4.64%
4.65
4.79
-2.92%
4.23
5.97
-29.15%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
1,354.29
1,212.60
1,390.99
1,069.00
678.68
673.50
769.39
642.97
506.86
480.10
418.07
Net Sales Growth
8.50%
-12.82%
30.12%
57.51%
0.77%
-12.46%
19.66%
26.85%
5.57%
14.84%
 
Cost Of Goods Sold
623.22
441.80
536.97
429.45
287.77
301.16
344.48
306.30
227.68
204.17
184.75
Gross Profit
731.07
770.80
854.02
639.56
390.91
372.34
424.91
336.66
279.19
275.93
233.32
GP Margin
53.98%
63.57%
61.40%
59.83%
57.60%
55.28%
55.23%
52.36%
55.08%
57.47%
55.81%
Total Expenditure
1,126.45
1,010.27
1,159.65
911.42
599.92
591.13
667.16
561.81
440.60
395.74
340.66
Power & Fuel Cost
-
64.60
63.17
45.42
31.36
31.58
34.73
33.12
29.26
27.82
19.74
% Of Sales
-
5.33%
4.54%
4.25%
4.62%
4.69%
4.51%
5.15%
5.77%
5.79%
4.72%
Employee Cost
-
58.05
46.04
41.50
34.29
33.43
33.27
27.61
24.78
21.18
16.39
% Of Sales
-
4.79%
3.31%
3.88%
5.05%
4.96%
4.32%
4.29%
4.89%
4.41%
3.92%
Manufacturing Exp.
-
318.97
357.94
251.09
159.21
149.73
160.07
121.89
99.48
87.26
74.70
% Of Sales
-
26.30%
25.73%
23.49%
23.46%
22.23%
20.80%
18.96%
19.63%
18.18%
17.87%
General & Admin Exp.
-
61.46
55.06
47.32
36.62
34.97
36.21
33.54
29.97
23.66
19.17
% Of Sales
-
5.07%
3.96%
4.43%
5.40%
5.19%
4.71%
5.22%
5.91%
4.93%
4.59%
Selling & Distn. Exp.
-
58.78
93.92
91.84
44.85
35.02
39.16
33.18
26.35
24.57
24.19
% Of Sales
-
4.85%
6.75%
8.59%
6.61%
5.20%
5.09%
5.16%
5.20%
5.12%
5.79%
Miscellaneous Exp.
-
6.61
6.54
4.82
5.82
5.24
19.25
6.17
3.08
7.07
24.19
% Of Sales
-
0.55%
0.47%
0.45%
0.86%
0.78%
2.50%
0.96%
0.61%
1.47%
0.41%
EBITDA
227.84
202.33
231.34
157.58
78.76
82.37
102.23
81.16
66.26
84.36
77.41
EBITDA Margin
16.82%
16.69%
16.63%
14.74%
11.60%
12.23%
13.29%
12.62%
13.07%
17.57%
18.52%
Other Income
12.80
12.45
15.21
5.76
2.82
7.34
3.08
8.35
7.28
2.02
2.57
Interest
38.19
37.49
34.64
28.02
27.28
39.21
46.95
48.60
44.13
37.18
33.61
Depreciation
38.73
33.55
26.46
22.98
20.30
20.19
20.87
18.81
15.89
13.38
12.22
PBT
163.73
143.74
185.45
112.33
34.00
30.31
37.49
22.10
13.53
35.83
34.15
Tax
48.29
42.64
48.88
30.94
-0.49
8.08
13.12
7.67
6.98
14.58
12.27
Tax Rate
29.49%
29.66%
26.36%
27.54%
-1.44%
26.66%
35.00%
34.71%
51.59%
40.69%
35.93%
PAT
115.43
101.10
136.56
81.39
34.49
22.23
24.36
14.42
6.54
21.25
21.88
PAT before Minority Interest
115.43
101.10
136.56
81.39
34.49
22.23
24.36
14.42
6.54
21.25
21.88
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
8.52%
8.34%
9.82%
7.61%
5.08%
3.30%
3.17%
2.24%
1.29%
4.43%
5.23%
PAT Growth
5.89%
-25.97%
67.78%
135.98%
55.15%
-8.74%
68.93%
120.49%
-69.22%
-2.88%
 
EPS
17.62
15.44
20.85
12.43
5.27
3.39
3.72
2.20
1.00
3.24
3.34

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
701.17
414.37
276.87
196.14
159.99
142.40
111.32
96.94
165.94
138.48
Share Capital
13.11
11.95
11.95
11.95
11.95
11.95
11.95
11.95
59.45
59.45
Total Reserves
688.06
402.43
264.93
184.20
148.05
130.46
99.38
84.99
106.50
79.03
Non-Current Liabilities
208.38
269.61
268.09
249.00
247.76
249.29
247.18
188.85
134.27
151.87
Secured Loans
70.67
101.83
102.27
74.89
65.81
71.10
86.93
107.83
56.15
45.15
Unsecured Loans
84.31
119.75
104.10
100.02
108.39
100.95
83.91
14.14
8.74
10.96
Long Term Provisions
1.45
0.60
2.68
4.00
5.02
5.66
3.41
2.65
1.78
0.67
Current Liabilities
415.89
366.95
369.96
327.73
327.57
365.16
423.12
407.86
325.34
205.60
Trade Payables
226.73
176.70
171.50
137.01
137.83
138.93
178.10
127.03
124.01
58.75
Other Current Liabilities
37.03
62.56
57.89
56.09
41.16
54.76
42.48
86.96
54.93
29.96
Short Term Borrowings
137.45
113.88
123.17
131.32
141.21
158.32
188.55
178.76
131.88
104.65
Short Term Provisions
14.67
13.81
17.40
3.30
7.37
13.16
13.98
15.11
14.53
12.24
Total Liabilities
1,325.44
1,050.93
914.92
772.87
735.32
756.85
781.62
693.65
625.55
495.95
Net Block
634.53
464.65
463.25
387.46
338.40
349.53
348.59
289.54
202.30
186.01
Gross Block
949.81
735.46
708.84
615.93
548.12
539.19
519.90
442.57
339.43
310.86
Accumulated Depreciation
315.28
270.80
245.59
228.46
209.72
189.66
171.31
153.02
137.14
124.85
Non Current Assets
670.27
582.70
497.36
423.78
389.97
384.50
380.55
370.21
285.11
236.68
Capital Work in Progress
15.80
97.96
5.41
23.96
36.37
19.39
16.95
61.90
66.12
44.09
Non Current Investment
0.30
0.23
0.22
0.29
1.21
1.24
0.28
0.59
0.39
0.30
Long Term Loans & Adv.
18.40
16.82
26.57
12.07
13.98
14.33
14.73
18.18
16.30
6.28
Other Non Current Assets
1.24
3.03
1.90
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
655.16
468.23
415.66
349.08
345.36
372.36
401.07
323.44
340.44
259.28
Current Investments
1.21
1.44
2.46
0.72
0.00
0.00
1.22
0.00
0.00
0.00
Inventories
316.94
207.44
167.76
190.75
207.66
189.46
182.33
170.28
172.92
115.61
Sundry Debtors
229.82
180.93
190.83
115.69
91.04
133.94
144.24
95.60
115.37
89.39
Cash & Bank
60.50
20.99
15.33
10.69
15.39
14.46
18.36
13.26
11.06
11.77
Other Current Assets
46.70
8.02
7.01
1.39
31.27
34.49
54.92
44.30
41.09
42.51
Short Term Loans & Adv.
39.39
49.43
32.25
29.84
24.49
33.81
53.79
40.61
37.49
37.49
Net Current Assets
239.28
101.29
45.70
21.36
17.79
7.19
-22.05
-84.42
15.10
53.67
Total Assets
1,325.43
1,050.93
913.02
772.86
735.33
756.86
781.62
693.65
625.55
495.96

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
67.50
134.25
94.36
67.37
49.23
99.99
89.16
73.19
38.75
12.67
PBT
143.74
185.45
112.33
34.00
30.31
37.49
14.42
6.54
21.25
34.15
Adjustment
62.26
56.40
46.51
45.06
52.12
62.57
72.00
63.41
61.22
42.89
Changes in Working Capital
-108.05
-59.22
-54.09
-5.04
-21.19
11.75
11.87
3.31
-36.16
-58.17
Cash after chg. in Working capital
97.96
182.63
104.75
74.02
61.23
111.82
98.29
73.26
46.32
18.87
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-30.46
-48.38
-10.39
-6.66
-12.01
-11.82
-9.14
-0.07
-7.57
-4.76
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-1.44
Cash From Investing Activity
-153.92
-118.36
-85.78
-51.82
-22.03
-23.31
-32.85
-97.85
-42.97
-8.85
Net Fixed Assets
-53.02
-24.59
-24.34
-41.03
-19.28
-16.48
-30.30
-95.09
-23.03
Net Investments
-114.36
-2.73
-0.94
0.52
0.32
-1.49
0.25
-4.06
-1.28
Others
13.46
-91.04
-60.50
-11.31
-3.07
-5.34
-2.80
1.30
-18.66
Cash from Financing Activity
88.13
-15.57
-8.57
-19.12
-23.61
-77.56
-56.16
24.94
3.52
1.20
Net Cash Inflow / Outflow
1.70
0.32
0.01
-3.57
3.58
-0.87
0.15
0.28
-0.71
5.02
Opening Cash & Equivalents
0.66
0.34
0.32
3.90
0.32
1.19
1.04
0.76
11.77
6.75
Closing Cash & Equivalent
2.36
0.66
0.34
0.32
3.90
0.32
1.19
1.04
11.06
11.77

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
107.00
69.37
46.35
164.19
133.93
119.21
93.19
81.14
99.15
76.16
ROA
8.51%
13.89%
9.64%
4.57%
2.98%
3.17%
1.96%
0.99%
3.79%
4.41%
ROE
18.13%
39.51%
34.41%
19.37%
14.70%
19.21%
13.85%
6.08%
20.29%
24.05%
ROCE
20.03%
30.71%
23.95%
12.05%
14.24%
17.17%
15.50%
14.40%
20.95%
21.47%
Fixed Asset Turnover
1.44
1.93
1.61
1.17
1.24
1.45
1.36
1.40
1.60
1.45
Receivable days
61.82
48.78
52.33
55.59
60.96
65.99
67.10
70.58
72.00
72.48
Inventory Days
78.92
49.23
61.20
107.13
107.61
88.19
98.65
114.81
101.46
93.74
Payable days
166.65
118.34
131.11
174.30
87.54
89.20
98.93
112.07
79.54
62.69
Cash Conversion Cycle
-25.91
-20.34
-17.57
-11.57
81.03
64.98
66.82
73.32
93.92
103.52
Total Debt/Equity
0.45
0.91
1.31
1.71
2.04
2.45
3.43
3.33
1.30
1.28
Interest Cover
4.83
6.35
5.01
2.25
1.77
1.80
1.45
1.31
1.96
2.02

News Update:


  • Vishnu Chemicals - Quarterly Results
    24th Jan 2025, 13:49 PM

    Read More
  • Vishnu Chemicals completes acquisition of Jayansree Pharma
    30th Nov 2024, 18:02 PM

    Pursuant to acquisition of shares of JPPL, it has become a wholly owned subsidiary of the company

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.